Psychiatry Tomorrow cover image

The SPRAVATO® Story with Dr. Hussesini K. Manji,

Psychiatry Tomorrow

00:00

Intro

This chapter explores the approval of esketamine as a transformative medication for treatment-resistant depression, examining its effects on psychiatry and mental health care. It delves into the science behind its action, the FDA approval process, and the challenges faced in its development.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner